FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Arm patents



      
           
This page is updated frequently with new Arm-related patent applications. Subscribe to the Arm RSS feed to automatically get the update: related Arm RSS feeds. RSS updates for this page: Arm RSS RSS


System and method of assisting prescription treatment fulfillment

System and method of assisting prescription treatment fulfillment

Enhanced engine performance with fuel temperature control

Enhanced engine performance with fuel temperature control

Enhanced engine performance with fuel temperature control

Aerial farm robot system for crop dusting, planting, fertilizing and other field jobs

Date/App# patent app List of recent Arm-related patents
10/09/14
20140304334
 Virtual multi-cluster clouds patent thumbnailVirtual multi-cluster clouds
An improved scalable object storage system includes methods and systems allowing multiple clusters to work together. Users working with a first cluster, or with a multi-cluster gateway, can ask for services and have the request or data transparently proxied to a second cluster.
10/09/14
20140303992
 System and method of assisting prescription treatment fulfillment patent thumbnailSystem and method of assisting prescription treatment fulfillment
Provided is a method and system for facilitating limited fulfillment of a prescription for a drug. An indication that an authorizing party has rejected an insurance claim submitted by a pharmacy for insurance coverage of at least a portion of a purchase price of a prescription drug on behalf of a patient is received over a network, in addition to an indication that prior authorization is required.
10/09/14
20140303874
 Enhanced engine performance with fuel temperature control patent thumbnailEnhanced engine performance with fuel temperature control
Methods and systems for utilizing heated fuel to compensate for a low cetane number, cetane number variance and sub-optimal engine cold-start performance in internal combustion engines are disclosed herein. Systems comprise a heater, a sensor, and an engine control unit (“ecu”).
10/09/14
20140303814
 Aerial farm robot system for crop dusting, planting, fertilizing and other field jobs patent thumbnailAerial farm robot system for crop dusting, planting, fertilizing and other field jobs
Modern farming is currently being done by powerful ground equipment or aircraft that weigh several tons and treat uniformly tens of hectares per hour. Automated farming can use small, agile, lightweight, energy-efficient automated robotic equipment that flies to do the same job, even able to farm on a plant-by-plant basis, allowing for new ways of farming.
10/09/14
20140303693
 Phototherapy device patent thumbnailPhototherapy device
A phototherapy device for applying light from a plurality of low-level light sources, such as leds or laser diodes, to male genitalia. The plurality of light sources are located on the interior of a tube, cup or helical band or ribbon, which is then applied to some or all portions of the male genitalia.
10/09/14
20140303692
 Therapeutic laser treatment device patent thumbnailTherapeutic laser treatment device
A therapeutic device includes a garment configured to be worn on a user's body over a treatment area. The therapeutic device includes a plurality of therapeutic electromagnetic (em) energy emitting devices, fixed to the garment at locations within the garment for irradiating the treatment area with em energy when the garment is worn over the treatment area.
10/09/14
20140303678
 Anti-splay apparatus patent thumbnailAnti-splay apparatus
An anti-splay apparatus having a bridge and frangible connection points for use with mechanical fasteners having a shank portion and a receiving member with opposing arms is provided. The bridge may take a number of forms including a ring, a notched ring, a tube, or a notched tube and the connection points join the opposing arms of the receiving member with the bridge.
10/09/14
20140303583
 Absorbent articles with barrier leg cuffs patent thumbnailAbsorbent articles with barrier leg cuffs
An absorbent article (20) for personal hygiene having a body-facing surface and an opposed garment-facing surface, the article having a front region (z1), a back region (z3) and an intermediate crotch region (z2). The absorbent article comprises on each longitudinal side a gasketing cuff (32) and a barrier leg cuff (34) formed from the same web of nonwoven barrier material (110).
10/09/14
20140303570
 Needle hub and disposal device for single-use needle assemblies patent thumbnailNeedle hub and disposal device for single-use needle assemblies
Described is a needle hub comprising a proximal end adapted to engage a medicament delivery device, a distal end having an opening, a shoulder disposed between the proximal end and the distal end, and a needle assembly engagement mechanism (f1) coupled to the shoulder and adapted to releasably engage a needle assembly. The needle assembly engagement mechanism (f1) includes two or more resilient arms adapted to releasably engage a retainer element on the needle assembly..
10/09/14
20140303532
 Computer user pain relieving vest or jacket patent thumbnailComputer user pain relieving vest or jacket
A computer user back brace is a garment which provides support to the upper and lower extremities in the back and also provides support to the chest, shoulder area and neck (optional) to prevent or alleviate pain while using a computer for an extended period of time. It can be made in the form of a vest or jacket to treat those areas covered by the garment.
10/09/14
20140303390
Carbonic anhydrase inhibitors and method of their production
Derivatives of boron cluster compounds of general formula i and their pharmaceutically acceptable salts and solvates, and their specific inhibition effect on the enzyme carbonic anhydrase ix, a protein overexpressed in cancer tissues. Methods of synthesis and the use of the novel derivatives.
10/09/14
20140303367
Methods for synthesizing molybdopterin precursor z derivatives
The disclosure also provides useful intermediates, derivatives, prodrugs, and pharmaceutically acceptable salts, solvates and hydrates of the formula (i) and formula (xiii) compounds. These compounds are useful for treating diseases associated with molybdenum cofactor deficiency..
10/09/14
20140303366
Certain 1h-imidazo[4,5-b]pyrazin-2(3h)-ones and 1h-imidazo[4,5-b]pyrazin-2-ols and methods for their use
Provided is a method of treating myasthenia gravis in a patient by administering to the patient an effective amount of a skeletal muscle troponin activator, or a pharmaceutically acceptable salt thereof.. .
10/09/14
20140303259
Method for enhancing the bioavailability of ospemifene
Or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, wherein said compound is administered orally to the individual in connection with the intake of food.. .
10/09/14
20140303248
N-benzylaniline derivative and uses thereof
A n-benzylaniline derivative and uses thereof. The derivative is a compound represented by formula i or a pharmaceutically acceptable salt thereof.
10/09/14
20140303232
Lipids and lipid compositions for the delivery of active agents
Or a pharmaceutically acceptable salt thereof, wherein r1-r4, l and x are defined herein. The compounds of formula (i) and pharmaceutically acceptable salts thereof are cationic lipids useful in the delivery of biologically active agents to cells and tissues..
10/09/14
20140303222
Dual-acting imidazole antihypertensive agents
Wherein: ar, r, r2-3, x, and r5-7 are as defined in the specification, and pharmaceutically acceptable salts thereof. These compounds have at1 receptor antagonist activity and neprilysin inhibition activity.
10/09/14
20140303206
3-pyridyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors
The invention provides certain 3-pyridyl carboxamide-containing compounds of the formula (i) (i) or pharmaceutically acceptable salts thereof, wherein a and b are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by spleen tyrosine kinase (syk) kinase..
10/09/14
20140303205
Modulators of cystic fibrosis transmembrane conductance regulator
Or a pharmaceutically acceptable salt thereof, wherein r is cooh or ch2oh.. .
10/09/14
20140303200
Polymorphic forms of naltrexone
This invention relates to the discovery of novel polymorphic forms of naltrexone, including solvates, hydrates, anhydrous and other crystalline forms and combinations thereof. These novel forms of naltrexone impart advantages in pharmaceutical formulations incorporating them, including sustained release, or long acting, formulations..
10/09/14
20140303195
Combination
A novel combination comprising the mek inhibitor n-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)6,8-dimethyl;-2,4,7-trioxo-3,4,6,7-tetrahydro-2h-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide, or a pharmaceutically acceptable salt or solvate thereof, with a mtor inhibitor, pharmaceutical compositions comprising the same and methods of using such combinations and compositions in the treatment of conditions in which the inhibition of mek and/or mtor is beneficial, e.g. Cancer..
10/09/14
20140303190
Tyrosine kinase inhibitors
The present disclosure provides compounds and pharmaceutically acceptable salts thereof that are tyrosine kinase inhibitors, in particular blk, bmx, egfr, her2, her4, itk, tec, btk, and txk and are therefore useful for the treatment of diseases treatable by inhibition of tyrosine kinases such as cancer and inflammatory diseases such as arthritis, and the like. Also provided are pharmaceutical compositions containing such compounds and pharmaceutically acceptable salts thereof and processes for preparing such compounds and pharmaceutically acceptable salts thereof..
10/09/14
20140303188
Substituted cyclopenta pyrimidine bicyclic compounds having antitmitotic and/or antitumor activity and methods of use thereof
And pharmaceutically acceptable salts, prodrugs, solvates, and hydrates thereof, having antimitotic activity, anti-multidrug resistance activity, such as for example p-glycoprotein inhibition, and antitumor activity, and which inhibit paclitaxel sensitive and resistant tumor cells. Also provided are methods of utilizing these compounds for treating tumor cells and inhibiting mitosis of cancerous cells..
10/09/14
20140303186
Nitrogen-containing fused ring compounds as crth2 antagonists
The present application relates to nitrogen-containing fused ring compounds shown by general formula (i), a pharmaceutically acceptable salt thereof and a stereoisomer thereof as crth2 antagonist, wherein x1, x2, x3, x4, x5, w, x, y, l1, l2, l3, a, b are as defined in the description; the present application further relates to a method for preparing the compounds, a pharmaceutical formulation and a pharmaceutical composition comprising the compounds, a use of the compounds for the manufacture of a medicament for the treatment and/or prevention of diseases related to activity of crth2.. .
10/09/14
20140303182
Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
A lacate salt of a compound of formula i or a tautomer of the compound, wherein formula i has the following structure and r1-r9 and r12-r14 are as defined herein. .
10/09/14
20140303171
Hiv protease inhibitors
Compounds of formula i are disclosed: wherein a, r1, r2, r3, r4a, r4b, r5, r6 and r7 are defined herein. The compounds encompassed by formula i include compounds which are hiv protease inhibitors.
10/09/14
20140303161
Tyrosine kinase inhibitors
The present disclosure provides compounds and pharmaceutically acceptable salts thereof that are tyrosine kinase inhibitors, in particular blk, bmx, egfr, her2, her4, itk, tec, btk, and txk and are therefore useful for the treatment of diseases treatable by inhibition of tyrosine kinases such as cancer and inflammatory diseases such as arthritis, and the like. Also provided are pharmaceutical compositions containing such compounds and pharmaceutically acceptable salts thereof and processes for preparing such compounds and pharmaceutically acceptable salts thereof..
10/09/14
20140303153
Novel inhibitor compounds of phosphodiesterase type 10a
The compounds of the formula i, the n-oxides, tautomers, the prodrugs and the pharmaceutically acceptable salts thereof are inhibitors of phosphodiesterase type 10a. Thus, the invention also relates to the use of the compounds of the formula i, the n-oxides, tautomers, the prodrugs and the pharmaceutically acceptable salts thereof for the manufacture of a medicament and which thus are suitable for treating or controlling of medical disorders selected from neurological disorders and psychiatric disorders, for ameliorating the symptoms associated with such disorders and for reducing the risk of such disorders..
10/09/14
20140303150
Ingenol-3-acylates iii and ingenol-3-carbamates
The invention relates to compounds of general formula i wherein r is heteroaryl optionally substituted by r7; or r is heterocycloalkyl or heterocycloalkenyl, optionally substituted by r8; or r is x wherein x is —nr11r12; and pharmaceutically acceptable salts, hydrates, or solvates thereof, for use—alone or in combination with one or more other pharmaceutically active compounds—in therapy, for preventing, treating or ameliorating diseases or conditions responsive to stimulation of neutrophil oxidative burst, responsive to stimulation of keratinocyte il-8 release or responsive to induction of necrosis.. .
10/09/14
20140303147
Acylated derivative of homoharringtonine, preparation method therefor, and application thereof
The present invention belongs to the field of natural medicine and pharmaceutical chemistry, and relates to novel homoharringtonine acylated derivatives of formula (i) and formula (ii) and a pharmaceutically acceptable salt thereof, to a process for the preparation of these compounds, compositions containing such compounds and their use in preparing antineoplastic medicaments.. .
10/09/14
20140303146
Method of treating mixed lineage leukemia gene-rearranged acute lymphoblastic leukemias
The present invention relates to a method of treating a warm-blooded animal, especially a human, having mixed lineage leukemia (mll rearranged all) comprising administering to said animal a therapeutically effective amount of a staurosporine derivative, especially pkc412 or a pharmaceutically acceptable salt thereof, alone or in combination with further therapeutic measures, for example, those defined herein; to the use of a staurosporine derivative for the preparation of a medicament for the treatment of mll rearranged all; and to a commercial package comprising a staurosporine derivative together with instructions for its use in the treatment of mll rearranged all.. .
10/09/14
20140303143
Benzoxazolinone compounds with selective activity in voltage-gated sodium channels
Disclosed are compounds of formula (a) or a salt thereof, wherein “het”, ra, and rb are defined herein, which have properties for blocking nav 1.7 ion channels found in peripheral and sympathetic neurons. Also described are pharmaceutical formulations comprising the compounds of formula (a) or their salts, and methods of treating neuropathic pain disorders using the same..
10/09/14
20140303139
Pyrimidines as sodium channel blockers
The present disclosure provides substituted pyrimidine compounds of formula (i), and the pharmaceutically acceptable salts, prodrugs, and solvates thereof, wherein a1, x, a2, w1, w2, e, z, and r4 are defined as set forth in the specification. The present disclosure is also directed to the use of compounds of formula (i) to treat a disorder responsive to the blockade of sodium channels.
10/09/14
20140303129
Methods of treating testosterone deficiency
Methods of treating a testosterone deficiency or its symptoms with a pharmaceutical formulation of testosterone esters are provided. The methods are designed toprovide optimum serum testosterone levels over an extended period..
10/09/14
20140303122
Casr agonists
By searching various kinds of compounds having casr agonistic activity, the present invention provides casr agonistic agents, pharmaceutical compositions, preventive or therapeutic agents for diarrhea and kokumi-imparting agents each of which comprise the compound. More specifically, the present invention provides casr agonistic agents, pharmaceutical compositions, preventive or therapeutic agents for diarrhea and kokumi-imparting agents each of which comprise a glutamic acid derivative having casr agonistic activity or pharmaceutically acceptable salts thereof..
10/09/14
20140303113
Hepatitis c viral infection treatment using a combination of compounds
Described herein is a combination that includes compound (a) and compound (b), or a pharmaceutically acceptable salt of the foregoing, for ameliorating and/or treating a hepatitis c viral infection.. .
10/09/14
20140302999
Method for determination of pharmacological properties of recombinant proteins
The present invention is directed to a method for obtaining an in vitro pharmacological model of a recombinant protein drug in a given host. A plurality of biomolecules are selected which are known or suspected to influence pharmacology of the recombinant protein in the host via a binding interaction with the recombinant protein.
10/09/14
20140302750
Valve reseating
Some embodiments comprise an apparatus for reseating valves, where an eccentric, non-rotational motion is applied in a grinding or lapping process. Other embodiments comprise a micrometer that permits repeatable application of pressure against a plate when the apparatus is removed and reinstalled.
10/09/14
20140302713
Electrical connector module
An electrical connector module for electrically connecting at least one connector to a printed circuit board of an electronic device includes at least one shielding jack having a top wall, two opposite side walls and at least one common wall. The walls of the shielding jack collectively define at least a slot therewithin for receiving the connectors and a front end and an opposite rear end.
10/09/14
20140302694
Latching connector assembly
An electrical cable connector includes a cable connector housing and a latch attached to the cable connector housing. The cable connector housing includes a first set of electrical contacts and a latch channel.
10/09/14
20140302537
Use of female mammal's urine for determination of fetal gender related characteristics
The present invention also provides a method of conceiving a baby of a desired gender in a female by applying to the female a pharmaceutical formulation with a specific sex hormone composition.. .
10/09/14
20140302271
Padding element for seats and method of manufacturing the same
Padding element for seats such as sofas, armchairs, chairs and armrests, wherein such seats have a support structure, or similar support structure for the human body or parts thereof, such as rest or anti-fatigue mats, anti-decubitus mattresses, shower mats, anti-impact mats, wherein the padding element is provided with a support surface for a user, wherein the padding element includes one film or covering, one gel layer adhering to part of the film or covering and one compact elastomeric layer having a surface for contact with the gel layer and with part of the film or covering and one surface for contact with the seat and/or with the support structure of the seat, wherein the compact elastomeric layer adheres to the gel layer and the film or covering; method for obtaining such padding element.. .
10/09/14
20140302237
Method for treating high strength fabric to be water repellent
The present invention relates to a method for treating high-strength fabric to be water-repellent, which includes dipping a high-strength fabric in a water-repellent agent composition to impregnate the high-strength fabric with the water-repellent agent composition, and then, using an air-suction machine to pick-up a part of the water-repellent agent composition impregnated in the high-strength fabric before drying and heating the same. The present invention has advantages in that a part of the water-repellent agent composition impregnated in the high-strength fabric may be uniformly picked-up during dipping, so as to improve water-repellent performance, especially, water-repellency after friction as well as initial water-repellency, and may effectively prevent occurrence of wrinkles on the high-strength fabric during water-repellent treatment.
10/09/14
20140302150
Dpp-iv inhibitor formulations
The present invention relates to a pharmaceutical formulation, characterized by comprising a dpp-iv inhibitor and polyvinylcaprolactam-polyvinyl acetate-polyethylene glycol graft copolymer.. .
10/09/14
20140302144
Multi-layered injectable self-assembling peptide scaffold hydrogels for long-term sustained release of human antibodies
The invention relates to a pharmaceutical formulation for sustained delivery of a therapeutic agent, preferably a protein, polypeptide, an antibody or an antibody fragment, comprising one or more gel forming peptides wherein the formulation exhibits sustained delivery for at least two weeks, three weeks, four weeks, five weeks, six weeks, seven weeks, eight weeks, nine weeks, ten weeks, eleven weeks, twelve weeks or more. In one embodiment, the invention relates to a formulation comprising self-assembling peptides that undergo sol-gel transition in the presence of an electrolyte solution such as biological fluids and salts.
10/09/14
20140302138
Extended release pharmaceutical compositions containing carbamazepine
An extended release matrix tablet for once daily administration comprising carbamazepine or a pharmaceutically acceptable salt thereof and one or more pharmaceutical excipients and process for preparing the same and is bioequivalent to fda approved carbamazepine extended release tablet formulations (tegretol®-xr).. .
10/09/14
20140302069
Modulators of c3a receptors
Heterocyclic compounds that modulate c3a receptors and their use in the treatment or prevention of inflammatory diseases, infectious diseases, cancers, metabolic disorders, obesity, type 2 diabetes, metabolic syndrome and associated cardiovascular diseases are described. The use of the compounds in stimulating or suppressing an immune response is also described together with pharmaceutical compositions comprising the compounds or their pharmaceutically acceptable salts..
10/09/14
20140302037
Bispecific-fc molecules
Described herein is a bispecific molecule containing an fc polypeptide chain and immunoglobulin variable regions. Also provided are pharmaceutical formulations comprising such molecules, nucleic acids encoding such molecules, host cells containing such nucleic acids, methods of making such molecules, and methods of using such molecules..
10/09/14
20140301959
Composition for deodorizing breath
A composition comprising an odor-suppressing mixture including parsley, alfalfa, oregano, and wheatgrass that cures halitosis. The odor-suppressing mixture comprises at least 50 weight percent of the composition.
10/09/14
20140301811
Vertical lift storage system and a method of operating a lift
There is provided a vertical lift storage system (101), comprising a storage rack (105) configured to store load units and a lift system with an upwardly and downwardly movable carrier structure (108), where the carrier structure (108) is configured to carry multiple load units at respective sections and with first transportation means configured to insert and withdraw respective load units into and from the storage rack. The system is characterized in that the carrier structure is configured with second transportation means to shift load units sideways on the carrier structure between its sections.
10/09/14
20140301771
Swing bracket of construction machine
Provided is a sufficiently reinforced swing bracket of a construction machine. The swing bracket includes a bracket body, a main connection portion connected to an upper slewing body of the construction machine, a swing-cylinder connection portion being protruded from one of right and left side parts of a lower end region of the bracket body to be connected to an end part of the swing cylinder and having a pair of supporting arms vertically opposed to each other with an interval, and a reinforcement portion for reinforcing a basal part of the swing-cylinder connection portion.
10/09/14
20140301731
Rotation mechanism for camera
A rotation mechanism includes a first bracket, a second bracket, a connection member, a pin, and a screw. The first bracket includes a base and two opposite pivot arms.
10/09/14
20140301091
Means for selective mounting of an illuminated or a translucent object
A mounting element for selective mounting of an object (1) for illumination or for transmission of light from a light source arranged behind the object, including two or more arms (5) which are arranged in one end (7) to be mounted so as to depend from a ceiling or to project from a wall, and in another and free end (6) are arranged to detachably engage, by a biasing force, in one of at least two alternative arresting seats (10, 16, 17) arranged to this purpose on an inner side of a frame (4) carrying the object, wherein a first of the arresting seats (10) is arranged to hold the frame into contact with the ceiling or the wall, and a second arresting seat (16; 17) is arranged to hold the frame while forming a gap (14) between the frame and the ceiling or wall.. .
10/09/14
20140301038
Apparatus for fastening expansion card
The present invention discloses an apparatus for fastening an expansion card, which includes: a “[” shaped bracket, where a pair of guide rails is symmetrically disposed on two arts of the “[” shaped bracket and a pair of first connection parts is symmetrically formed, and a backplane is permanently connected to the bottom of the “[” shaped bracket, where at least one expansion card slot is disposed on the backplane; and a “]” shaped compression element for the expansion card, where a pair of sliding blocks is symmetrically formed on two arms of the “]” shaped compression element for the expansion card and a pair of second connection parts is symmetrically formed, where each sliding block is embedded in a guide rail and can be slid along the guide rail; the present invention improves convenience of assembly and maintenance of an expansion card.. .
10/09/14
20140301027
Cold row encapsulation for server farm cooling system
Apparatuses, methods, and systems directed to efficient cooling of data centers. Some embodiments of the invention allow encapsulation of cold rows through an enclosure and allow one or more fans to draw cold air from the cold row encapsulation structure to cool servers installed on the server racks.


Popular terms: [SEARCH]



Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Arm for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Arm with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.4754

4379

1 - 1 - 74